NSCLC STAGE II
Clinical trials for NSCLC STAGE II explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE II trials appear
Sign up with your email to follow new studies for NSCLC STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to shield lungs during cancer radiation
Disease control Recruiting nowThis study is testing whether a drug called BIO 300 can help protect the lungs of patients who have both early-stage lung cancer and a separate lung scarring disease (interstitial lung disease) when they receive radiation therapy. The main goal is to see if BIO 300 can prevent se…
Matched conditions: NSCLC STAGE II
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug combo aims to shrink lung tumors before surgery
Disease control Recruiting nowThis study is testing a combination of two immunotherapy drugs plus standard chemotherapy given before surgery for patients with stage 2 or 3 non-small cell lung cancer. The goal is to see if this three-drug approach can shrink tumors more effectively before they are surgically r…
Matched conditions: NSCLC STAGE II
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Can exercise help lung cancer patients during treatment?
Symptom relief Recruiting nowThis pilot study is testing whether a personalized, home-based exercise program is practical and safe for people with stage II or III lung cancer who are undergoing combined treatments like chemotherapy and surgery. The program is delivered through telehealth and starts before tr…
Matched conditions: NSCLC STAGE II
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC